Seroprevalence of hepatitis <scp>E</scp> virus (<scp>HEV</scp>) and detection of <scp>HEV RNA</scp> with a transcription‐mediated amplification assay in blood donors from <scp>C</scp>atalonia (<scp>S</scp>pain)

Abstract

The Procleix HEV ID-NAT screening system has provided evidence of HEV RNA presence in Catalan blood donors. Further data are needed to assess the impact of HEV infection in at-risk patients to design the best strategy to increase blood safety.